Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Aggression × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 451 Carcinoma, Non-Small-Cell Lung 430 Prostatic Neoplasms 288 Multiple Myeloma 232 Neoplasms 223 Colorectal Neoplasms 206 Leukemia, Myeloid, Acute 186 Squamous Cell Carcinoma of Head and Neck 180 Lung Neoplasms 178 Neoplasm Metastasis 168 Carcinoma, Hepatocellular 163 Pancreatic Neoplasms 157 Melanoma 151 Triple Negative Breast Neoplasms 141 Recurrence 127 Ovarian Neoplasms 126 Glioblastoma 115 Brain Neoplasms 115 Lymphoma 113 Leukemia, Lymphocytic, Chronic, B-Cell 105 Precursor Cell Lymphoblastic Leukemia-Lymphoma 103 Carcinoma, Renal Cell 103 Stomach Neoplasms 101 Sarcoma 101 Lymphoma, Large B-Cell, Diffuse 101 Head and Neck Neoplasms 101 Myelodysplastic Syndromes 92 Rectal Neoplasms 86 Endometrial Neoplasms 85 Urinary Bladder Neoplasms 83

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06534437 2025-09-29

JASPIS-01

Ryvu Therapeutics SA

Phase 2 Recruiting

Aggression, Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡